FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 117 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 6.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $86,000 | -83.9% | 18,790 | -86.3% | 0.00% | -85.2% |
| Q3 2019 | $533,000 | -15.5% | 137,569 | +31.6% | 0.03% | -25.0% |
| Q2 2019 | $631,000 | +60.6% | 104,569 | +270.0% | 0.04% | +100.0% |
| Q3 2018 | $393,000 | -50.6% | 28,259 | -43.9% | 0.02% | -43.8% |
| Q2 2018 | $796,000 | -70.8% | 50,369 | -68.3% | 0.03% | -70.6% |
| Q1 2018 | $2,727,000 | -18.3% | 158,769 | +4.3% | 0.11% | -26.4% |
| Q4 2017 | $3,337,000 | +226.8% | 152,269 | +509.7% | 0.15% | +184.6% |
| Q3 2017 | $1,021,000 | +85.6% | 24,974 | +22.5% | 0.05% | +147.6% |
| Q4 2014 | $550,000 | – | 20,385 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|